• Policy
• Daewoong to replace Astellas Irribow’s gap
• by Lee, Hye-Kyung Dec 23, 2024 05:49am

• Policy
• Price of Pulmicort raised again upon request
• by Lee, Tak-Sun Dec 23, 2024 05:49am

• Policy
• Gilead starts trial for its autoimmune disease drug in KOR
• by Lee, Hye-Kyung Dec 20, 2024 05:47am

• Policy
• Keytruda’s reimb for gastric cancer will be redeliberated
• by Lee, Tak-Sun Dec 20, 2024 05:46am

• Policy
• Basic refund type-drugs granted early RSA termination
• by Lee, Tak-Sun Dec 20, 2024 05:46am

• Policy
• Cinacalcet impurities spread…Huons recalls product
• by Lee, Hye-Kyung Dec 19, 2024 05:53am

• Policy
• Sanofi signs PVA negotiations for hemophilia drug 'Alprolix'
• by Lee, Tak-Sun Dec 19, 2024 05:52am

• Policy
• Hyperphosphatemia treatments undergo generation change
• by Lee, Tak-Sun Dec 19, 2024 05:52am

• Policy
• Prior notification of drug permit changes extended to 2025
• by Lee, Hye-Kyung Dec 19, 2024 05:52am

• Policy
• Generic drugs without originals released in KOR
• by Lee, Tak-Sun Dec 18, 2024 05:54am